Minimizing Drug Product Loss In Manufacturing

High-value drug modalities such as monoclonal antibodies, oligonucleotides, and gene therapies require manufacturing strategies where every drop of material truly counts. With limited batch sizes, high production costs, and strict regulatory expectations, minimizing loss while maintaining product integrity is critical. This video explores how optimized analytical testing, reduced material wastage, and advanced sterile fill-finish technologies can work together to preserve valuable GMP material without compromising quality.

Discover how thoughtful process design and smarter manufacturing decisions can significantly reduce product loss, mitigate contamination risk, and improve overall efficiency. By integrating innovative approaches to handling, testing, and aseptic processing, manufacturers can enhance sterility assurance while maximizing yield — ultimately supporting safer, more reliable, and cost-effective drug production.